External liquid medicine

A liquid medicine and wound technology, applied in the field of external medicine liquid, can solve the problems of narrow application area of ​​medicine and poor healing effect, and achieve the effects of protecting wound surface, preventing the invasion of bacteria and reducing the chance of infection

Inactive Publication Date: 2021-10-08
李东临
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Aiming at the deficiencies of the prior art, the present invention provides a liquid medicine for external use, which solves the problems of narrow application area of ​​the medicine and poor healing effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The embodiment of the present invention provides a liquid medicine for external use, including the following raw materials in parts by mass:

[0034]The quality composition of raw materials for the external medicinal liquid used to treat new wounds is as follows: 20 parts of green bark leaves, 6 parts of Polygonum cuspidatum, 2 parts of comfrey, 2 parts of Astragalus, 180 parts of water, the setting of various drug combinations, after the liquid is applied to the affected part When treating new wounds, it can not only inhibit the reproduction of bacteria, but also enable the new wounds to heal quickly, reduce swelling and pain, and promote the self-repair of soft tissues, so that the wounds of burns and scalds can recover quickly and reduce the chance of infection. Inherent characteristics, it has a barrier effect on microorganisms in the external environment, so clinical application shows that its wound infection rate is only 2.6%, which is greatly reduced compared with...

Embodiment 2

[0053] The embodiment of the present invention provides a liquid medicine for external use, including the following raw materials in parts by mass:

[0054] The quality composition of raw materials of the external medicinal liquid for treating new wounds is as follows: 10 parts of green bark leaves, 2 parts of Polygonum cuspidatum, 1 part of comfrey, 1 part of astragalus, and 90 parts of water.

[0055] The mass composition of raw materials for external medicinal liquid for treating old wounds is as follows: 15 parts of green bark leaves, 3 parts of Polygonum cuspidatum, 1.5 parts of comfrey, 1.5 parts of astragalus, and 70 parts of water.

[0056] The quality composition of raw materials for external medicinal liquid for high-efficiency antibacterial and routinely infected wounds is as follows: 8 parts of green bark leaves, 0.8 parts of comfrey, 0.8 parts of astragalus, 2.5 parts of knotweed, 0.3 parts of peppermint oil, and 78 parts of water;

[0057] The medicinal solution ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides an external liquid medicine, and relates to the technical field of traditional Chinese medicines. The external liquid medicine comprises the following raw materials in parts by mass: 10-20 parts of green tangerine leaves, 2-6 parts of polygonum cuspidatum, 1-2 parts of lithospermum, 1-2 parts of astragalus membranaceus and 90-180 parts of water; the external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 15-25 parts of green tangerine leaves, 3-8 parts of polygonum cuspidatum, 1.5-2.5 parts of lithospermum, 1.5-2.5 parts of astragalus membranaceus and 70-160 parts of water; and the external liquid medicine for efficient bacteriostasis and conventional infection wounds comprises the following raw materials in parts by mass: 8-18 parts of green tangerine leaves, 0.8-1.3 parts of lithospermum, 0.8-1.3 parts of astragalus membranaceus, 2.5-5 parts of polygonum cuspidatum, 0.3-0.4 part of peppermint oil and 78-159 parts of water. Through flexible combination of medicines, the external liquid medicine has a good treatment effect on new and old burns and scalds, viral wounds and dental ulcer, and is worthy of vigorous popularization.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a medicinal liquid for external use. Background technique [0002] Burns and scalds are a kind of sudden common disease, and apt to occur in summer and autumn and exposed parts of the human body, the mild ones bring pain to the patient, and the severe ones are life-threatening. At present, there are many kinds of medicines for treating burns and scalds in the domestic market, but the effects are unsatisfactory. Clinically, no matter whether bandage therapy or exposure therapy is used, there are problems such as slow curative effect, easy infection, cumbersome treatment methods, high cost, deep second-degree burns and scalds, Artificial skin grafting is required, and scars and other defects will remain in varying degrees after healing. Bed sores (pressure sores) are tissue necrosis lesions caused by long-term pressure on local tissues of the body, blood circul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61P17/02A61P3/10A61P29/00A61P1/02A61P17/00A61P37/08
CPCA61K36/752A61K36/704A61K36/30A61K36/481A61K9/0014A61P17/02A61P3/10A61P29/00A61P1/02A61P17/00A61P37/08A61K2236/13A61K2236/15A61K2236/331A61K2236/53A61K2236/39A61K2300/00
Inventor 李东临
Owner 李东临
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products